The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes

Clinical trial NCT02002130 · COMPLETED

Trial details

NCT number: NCT02002130
Sponsor: University of Alabama at Birmingham
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type I Diabetes

Start date: 2015-01-01
Primary completion: 2021-10-15
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.